Blogs

• "US-backed vaccine patent waiver: pros and cons explained'' The Conversation, May 6, 2021.
• "Toilet paper in the time of Corona." UEA Blog, March 18, 2020.
• "Pfizer and Flynn: How are `excessive' prices for generic drugs possible and should competition authorities do more about exploitative pricing?" CCP Blog, December 16, 2016.
• "Clinton's proposed ban on pay-for-delay deals would do little to lower drug prices." STAT September 28, 2016. (Cross-posted at CCP blogs site.)
• "The logic of selling cheaper 'generics' for drug companies such as Mylan." The Conversation, September 2, 2016. (Cross-posted as "Why have Mylan launched a generic EpiPen?'' at CCP Blog)
• "Drug Prices post-Brexit -- an expensive pill to swallow?'' The Conversation, June 8, 2016.
• "The Economics of Pay To Delay Deals" CCP Blog, February 16, 2016.
• "The Economics of a $750 Pill" CCP Blog, September 23, 2015.

This page was last updated on Aug/20/2022